Q&A: Avoidant/Restrictive Food Intake Disorder in Crohn’s Disease and Ulcerative Colitis
In inflammatory bowel disease, empiric or overall food avoidance increases the risk for food avoidance and avoidant/restrictive food intake disorder.
Read MoreMay 21, 2024
In inflammatory bowel disease, empiric or overall food avoidance increases the risk for food avoidance and avoidant/restrictive food intake disorder.
Read MoreMay 20, 2024
In Part 2, Dr. Brockway reviews non-pharmacological interventions, such as physical therapy, for pain management in COPD.
Read MoreMay 15, 2024
Researchers analyzed whether valbenazine’s impact on tardive dyskinesia symptoms varied between patients with schizophrenia versus bipolar disorder.
Read MoreMay 13, 2024
Patients and clinicians generally report suboptimal disease control at lower rates than those determined by Selecting Therapeutic Targets in IBD-II metrics.
Read MoreMay 9, 2024
Optimizing pain management strategies can help physicians better support patients with COPD in their journey towards improved health and well-being.
Read MoreMay 1, 2024
Authors of a recent review outlined barriers to tardive dyskinesia diagnosis and how neurologists and psychiatrists can collaborate to optimize care.
Read MoreApr 30, 2024
Among the landscape of HF, comorbidities such as anemia and iron deficiency have garnered attention for their potential impact on patient outcomes.
Read MoreApr 26, 2024
The following is a summary of “Effect of iron deficiency on RV function in acute decompensated...
Read MoreApr 24, 2024
Iron deficiency anemia is common in patients with Crohn’s disease and ulcerative colitis, but iron supplementation also could be an effective treatment.
Read MoreApr 24, 2024
Dr. Brockway reviews non-pharmacological interventions, such as physical therapy, for pain management in COPD.
Read MoreApr 12, 2024
Vitamin E has shown potential for targeting the underlying mechanisms of inflammatory bowel disease, but more research into its clinical application is needed.
Read MoreApr 12, 2024
Comorbidities complicate COPD management, but the underlying mechanisms driving both conditions present an opportunity for therapeutic advancements.
Read MoreApr 11, 2024
Only half of patients with metastatic castration-resistant prostate cancer were tested for HRR mutations, and PARP inhibitors were underused.
Read MoreApr 11, 2024
Dr. Eiry Roberts discusses why clinicians should avoid anticholinergics in patients with tardive...
Read MoreApr 10, 2024
The administration of ferric carboxymaltose in patients with decompensated acute HF and iron...
Read MoreApr 5, 2024
Due to the critical nature of acute HF (AHF), accurately gauging the risk for mortality may help...
Read MoreApr 4, 2024
Iron deficiency is a widely prevalent finding in patients with heart failure, observed on average...
Read MoreApr 3, 2024
Men with metastatic hormone-sensitive prostate cancer who experience baseline bone pain have worse survival outcomes despite treatment intensification.
Read MoreMar 29, 2024
Various sessions at the 2024 ASCO Genitourinary Cancers Symposium reviewed health care discrimination and disparities among patients with prostate cancer.
Read MoreMar 29, 2024
Researchers emphasized the importance of bone-protective agents in patients treated for metastatic castration-resistant prostate cancer.
Read More